Back to Research
Ncd Burden Brief 2026-05-20

Bangladesh's NCD Crisis

NCDs at 71% of deaths, expired 2018-2025 Action Plan with no successor, hospital-only cancer registry (167,256 cases 2022), and 74% out-of-pocket health spending.

Bangladesh's NCD Crisis

70% of Deaths, an Expired Action Plan, and the Cancer Registry Gap

BDPolicy Lab | Health Policy Unit · 2026-05-20

Abstract

Noncommunicable diseases (NCDs) now account for approximately 71 percent of all deaths in Bangladesh (WHO, NBPH/IEDCR 2025), yet the country's sole coordinating instrument, the Multisectoral NCD Action Plan 2018-2025, expired at end-2025 with no successor announced. Health Minister Sardar Md Sakhawat Hossain, who took office on 18 February 2026 in Prime Minister Tarique Rahman's BNP government, has named corruption-free service delivery as his top priority, but NCD surveillance and financing reform remain unaddressed. Out-of-pocket spending absorbs roughly 74 percent of current health expenditure (WHO GHED 2019 vintage), the highest burden in the region after Afghanistan, and total health expenditure stands at only 2.4 percent of GDP (WB WDI 2021), against WHO's recommended 5 percent. This brief documents the four leading NCD burdens, the cancer-registry coverage gap, and three actionable policy levers for the new government.

Key findings

  • The Multisectoral NCD Action Plan 2018-2025 expired with no successor. Coordinated under the DGHS Non-communicable Disease Control (NCDC) unit, the seven-year plan involving 35 ministries lapsed at end-2025. No successor plan, interim operational framework, or financing commitment had been announced by May 2026. The STEPS Survey last fielded in 2018 is now eight years overdue, leaving Bangladesh without current population-based NCD risk-factor surveillance.
  • The national cancer registry is hospital-based, covering a fraction of true incidence. Bangladesh recorded 167,256 cancer cases in 2022 (Jabed Iqbal et al., Cancer Control 2025, doi:10.1177/10732748251323757, PMC11869311), but the registry is hospital-based and captures only cases presenting at NICRH and affiliated units. Bangladesh has no population-based cancer registry. GLOBOCAN 2022 estimates 177,285 new cancer cases for Bangladesh that year, implying a registration shortfall of roughly 10,000 cases. Only 4 medical-college hospitals run dedicated cancer units; BSMMU, NICRH, and NICVD remain the principal tertiary referral hubs for a population of 173 million.
  • Out-of-pocket financing at 74 percent violates SDG 3.8 UHC equity thresholds. WHO GHED 2019-vintage data place Bangladesh's OOP share of current health expenditure at approximately 74 percent, compared with 60 percent in Pakistan and 50 percent in India. A 2022 BIDS estimate found that catastrophic health spending pushed 6.1 million Bangladeshis into poverty annually. UHC Service Coverage Index stood at 52 out of 100 (WHO/WB 2021), below the South Asia average. Total health expenditure at 2.4 percent of GDP is among the lowest of all lower-middle-income countries.
  • Diabetes and hypertension burdens are large and undertreated. BDHS 2017-18 biomarker module records age-standardized diabetes prevalence at 12.8 percent among adults (PLOS One, PMC9064112), with 61.5 percent of those affected unaware of their status. Hypertension prevalence stands at 26.2 percent age-standardized (BMC Public Health, doi:10.1186/s12889-021-11234-5). Both conditions are substantially higher in urban areas. The IDF Diabetes Atlas 10th edition (2021) ranked Bangladesh 8th globally by absolute count of adults with diabetes (13.1 million), based on the same BDHS 2017-18 survey.
  • Tobacco use at 35.3 percent and NCDC capacity gaps compound NCD risk. GATS Bangladesh 2017 (WHO/CDC) records all-tobacco-use prevalence at 35.3 percent of adults (down from 43.3 percent in GATS 2009). Smoked tobacco stood at 16.4 percent and smokeless tobacco at 20.6 percent. Tobacco is the leading modifiable NCD risk factor. The NCDC unit coordinates surveillance and screening; NCD corners are operational at upazila health complexes across the country, but staffing, diagnostics, and drug availability remain inconsistent below district level.
NCD share of deaths (%)
71
WHO/NBPH 2025
Cancer cases registered 2022
167,256
hospital-based registry (Iqbal 2025)
Diabetes prevalence adults (%)
12.8
age-standardized, BDHS 2017-18
Hypertension prevalence adults (%)
26.2
age-standardized, BDHS 2017-18
OOP health spend (%)
74
% current health exp., WHO GHED 2019

Noncommunicable diseases kill approximately 71 percent of all Bangladeshis who die each year. Cardiovascular diseases are the largest single category, accounting for roughly 25 percent of all deaths; heart disease adds another 23 percent. Cancers cause approximately 11 percent of deaths. Chronic respiratory diseases and diabetes together contribute most of the remainder. WHO Bangladesh (2025) and the National Bioinformatics and Population Health Institute (NBPH/IEDCR) both corroborate this distribution.

The Expired Action Plan and the Governance Vacuum

The Multisectoral NCD Action Plan 2018-2025, coordinated by the DGHS Non-communicable Disease Control (NCDC) unit and endorsed by 35 ministries, was Bangladesh's only cross-cutting NCD governance instrument. It lapsed at end-2025. No successor framework had been publicly announced by mid-May 2026. The Ministry of Health and Family Welfare, now led by Health Minister Sardar Md Sakhawat Hossain since 18 February 2026, has not yet tabled a replacement.

The surveillance system has a parallel gap. Bangladesh's STEPS Survey, the standard WHO risk-factor assessment tool, was last conducted in 2018. A subsequent round is now eight years overdue. Without current population-based data on tobacco use, physical activity, salt intake, and metabolic risk factors, neither trend analysis nor programme targeting is reliable.

Cancer Registry: Hospital Gates, Not Population Coverage

The 2022 National Cancer Registry recorded 167,256 cases (Jabed Iqbal et al., Cancer Control 2025, PMC11869311). The registry is hospital-based: it captures only patients presenting to NICRH, BSMMU, NICVD, and a handful of affiliated medical-college units. Bangladesh has no population-based cancer registry.

GLOBOCAN 2022 estimates 177,285 new cancer cases for the year, implying the hospital registry missed roughly 10,000 incident cases, and that figure almost certainly understates true incidence given rural access barriers. Cervical cancer and esophageal cancer are among the most prevalent in the registry data; lung cancer is the leading cause of cancer mortality among men.

Financing Distress: OOP, GDP Share, and UHC Failure

Out-of-pocket spending constitutes approximately 74 percent of current health expenditure in Bangladesh (WHO GHED 2019 vintage; WB WDI SH.XPD.OOPC.CH.ZS). That share is below Afghanistan regionally but above every other South Asian economy, including Pakistan at approximately 60 percent and India at approximately 50 percent. A BIDS analysis covering 2022 found that catastrophic health spending pushed 6.1 million households into poverty annually.

Total health expenditure stands at roughly 2.4 percent of GDP (WB WDI SH.XPD.CHEX.GD.ZS, 2021 vintage), against WHO's recommended floor of 5 percent. Public sector spending is approximately 0.44 percent of GDP (WB WDI SH.XPD.GHED.GD.ZS, 2021). The WHO/WB UHC Service Coverage Index placed Bangladesh at 52 out of 100 in 2021, behind India (61), Vietnam (73), and Sri Lanka (76).

Diabetes and Hypertension: Scale, Unawareness, and Undertreatment

BDHS 2017-18 biomarker data record age-standardized diabetes prevalence at 12.8 percent among adults (PLOS One, PMC9064112). Urban areas record 12.0 percent; rural areas record 8.4 percent. More than 61 percent of adults with diabetes were unaware of their condition; only 35 percent were receiving regular treatment. The IDF Diabetes Atlas 10th edition (2021) estimated 13.1 million adults with diabetes in Bangladesh, ranking it 8th globally by absolute count, using BDHS 2017-18 as the primary source.

Hypertension prevalence is age-standardized at 26.2 percent of adults per BDHS 2017-18 (BMC Public Health, doi:10.1186/s12889-021-11234-5). Prevalence rises steeply with age and is higher in urban and higher-wealth quintiles. Hypertension is the principal risk factor for cardiovascular mortality, Bangladesh's largest cause of NCD death.

Tobacco: Progress Stalled, Smokeless Tobacco Overlooked

GATS Bangladesh 2017 (WHO/CDC) recorded all-tobacco-use prevalence at 35.3 percent of adults aged 15 and above, down from 43.3 percent in GATS 2009. The decline masks a composition shift: smoked tobacco fell from 23.0 percent to 16.4 percent, but smokeless tobacco remains at 20.6 percent and is concentrated among women. Tobacco is the leading modifiable NCD risk factor; its prevalence at more than one-third of the adult population undermines every other NCD intervention.

Three Priority Reform Levers

A successor NCD action plan is overdue. The NCDC unit should table a Multisectoral NCD Action Plan 2026-2030 that includes a binding surveillance calendar, NCD corner drug supply standards, and a costed public-financing target.

A population-based cancer registry is achievable within two budget cycles. NICRH is the natural anchor institution. A sentinel-district registry covering Dhaka, Chittagong, and Sylhet divisions would deliver representative incidence data at a fraction of a national roll-out cost, following the model of IARC's pilot frameworks in comparable low-middle-income settings.

OOP reduction requires mandatory pooling, not just supply-side expansion. Community clinic utilisation gains since 2009 have not translated into reduced financial catastrophe because secondary and tertiary care remain almost entirely OOP. A scaled-up health protection scheme targeted at the bottom two wealth quintiles, with NCD medicines on the essential list, is the minimum viable intervention for SDG 3.8 compliance.

BDPolicy Lab | bdpolicylab.com | CC BY 4.0
BDPolicy Lab | bdpolicylab.com | CC BY 4.0
BDPolicy Lab | bdpolicylab.com | CC BY 4.0

Data and methodology

NCD share of deaths: WHO Bangladesh country office and NBPH/IEDCR NCD overview, 2025. Source URL: https://nbph.iedcr.gov.bd/non-communicable-diseases-and-their-prevention-a-global-regional-and-bangladesh-perspective/ Cancer registry: Jabed Iqbal et al., 'National Cancer Registries in Bangladesh and Social Determinants of Health: Challenging Cancer Disparities', Cancer Control, published 27 February 2025, doi:10.1177/10732748251323757, PMC11869311. Data year: 2022. Registry type: hospital-based (NICRH and affiliates), not population-based. Diabetes prevalence: BDHS 2017-18 biomarker module (NIPORT/ICF, n=23,539 adults 18+); age-standardized figure 12.8% reported in Fottrell et al. (2022), PMC9064112, PLOS One. IDF Diabetes Atlas 10th edition (2021) Bangladesh estimates are derived from BDHS 2017-18. Hypertension prevalence: age-standardized 26.2% from BDHS 2017-18 biomarker; BMC Public Health doi:10.1186/s12889-021-11234-5. Tobacco use: Global Adult Tobacco Survey (GATS) Bangladesh 2017, conducted by CDC/WHO; all-tobacco-use 35.3% among adults 15+. Source: WHO Bangladesh GATS 2017 dissemination and NTCC Bangladesh report (ntcc.gov.bd). OOP health spending: WHO Global Health Expenditure Database (GHED) 2019 vintage, World Bank WDI indicator SH.XPD.OOPC.CH.ZS. The Joint Learning Network Bangladesh health expenditure brief (February 2021) cites 72 percent for the same GHED vintage. Total health expenditure as percent of GDP: World Bank WDI SH.XPD.CHEX.GD.ZS, 2021 vintage (2.36%), rounded to 2.4% for presentation. Multisectoral NCD Action Plan 2018-2025: DGHS Bangladesh, endorsed 2018; full text at cdn.who.int (ban-ncd-action-plan-2018-2025.pdf). No successor plan found in public sources as of 16 May 2026. Health Minister appointment: Bangladeshi national media (The Daily Star, TBS, Dhaka Tribune), February 2026; minister sworn 18 February 2026. Surveillance gap: STEPS Survey last fielded 2018; no subsequent round confirmed.

Sources

WHO Bangladesh NCD integration feature 2025: https://www.who.int/bangladesh/news/feature-stories/item/bangladesh-moves-to-integrate-ncd-and-mental-health-care-into-emergency-preparedness | NBPH/IEDCR NCD overview: https://nbph.iedcr.gov.bd/non-communicable-diseases-and-their-prevention-a-global-regional-and-bangladesh-perspective/ | NCD Alliance 35-ministry NCD event 2025: https://ncdalliance.org/stories/news-blogs/2025/35-ministries-unite-ncd-prevention-and-control-bangladesh | Jabed Iqbal et al. Cancer Control 2025 (PMC11869311): https://pmc.ncbi.nlm.nih.gov/articles/PMC11869311/ | DGHS Multisectoral NCD Action Plan 2018-2025 (WHO CDN): https://cdn.who.int/media/docs/default-source/searo/ncd/ban-ncd-action-plan-2018-2025.pdf | IDF Diabetes Atlas 10th edition 2021 Bangladesh: https://diabetesatlas.org/data-by-location/country/bangladesh/ | BDHS 2017-18 diabetes/hypertension (PMC9064112 PLOS One): https://pmc.ncbi.nlm.nih.gov/articles/PMC9064112/ | BDHS 2017-18 hypertension (BMC Public Health): https://link.springer.com/article/10.1186/s12889-021-11234-5 | GATS Bangladesh 2017 WHO dissemination: https://www.who.int/bangladesh/news/detail/19-09-2019-dissemination-of-findings-of-the-global-adult-tobacco-survey-(gats)-bangladesh-2017 | GATS Bangladesh 2017 NTCC report: https://ntcc.gov.bd/ntcc/uploads/editor/files/GATS%20Report%20Final-2017_20%20MB.PDF | WHO GHED Bangladesh OOP (World Bank WDI): https://data.worldbank.org/indicator/SH.XPD.OOPC.CH.ZS?locations=BD | World Bank WDI health expenditure GDP: https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS?locations=BD | GLOBOCAN 2022 Bangladesh factsheet: https://gco.iarc.who.int/media/globocan/factsheets/populations/50-bangladesh-fact-sheet.pdf | DGHS NCDC: https://ncdc.gov.bd

BDPolicy Lab | bdpolicylab.com | CC BY 4.0

Created: 2026-05-20 14:47:23.854403 Updated: 2026-05-20 14:47:23.854403